↓ Skip to main content

JIMD Reports, Volume 30

Overview of attention for book
Cover of 'JIMD Reports, Volume 30'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 475 Identification of Cryptic Novel α-Galactosidase A Gene Mutations: Abnormal mRNA Splicing and Large Deletions
  3. Altmetric Badge
    Chapter 510 Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.
  4. Altmetric Badge
    Chapter 522 A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV
  5. Altmetric Badge
    Chapter 523 The Effect of Multiple Sulfatase Deficiency (MSD) on Dental Development: Can We Use the Teeth as an Early Diagnostic Tool?
  6. Altmetric Badge
    Chapter 524 Biomarkers in a Taurine Trial for Succinic Semialdehyde Dehydrogenase Deficiency
  7. Altmetric Badge
    Chapter 527 Multidisciplinary Team Approach Is Key for Managing Pregnancy and Delivery in Patient with Rare, Complex MPS I
  8. Altmetric Badge
    Chapter 530 Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux–Lamy Syndrome
  9. Altmetric Badge
    Chapter 531 A New Approach for Fast Metabolic Diagnostics in CMAMMA
  10. Altmetric Badge
    Chapter 532 Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor
  11. Altmetric Badge
    Chapter 533 Pilot Experience with an External Quality Assurance Scheme for Acylcarnitines in Plasma/Serum
  12. Altmetric Badge
    Chapter 534 A Founder Effect for the HGD G360R Mutation in Italy: Implications for a Regional Screening of Alkaptonuria.
  13. Altmetric Badge
    Chapter 536 Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency
  14. Altmetric Badge
    Chapter 538 ECHS1 Deficiency as a Cause of Severe Neonatal Lactic Acidosis
  15. Altmetric Badge
    Chapter 539 Chronic Oral l -Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions
  16. Altmetric Badge
    Chapter 540 Erratum to: Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures
  17. Altmetric Badge
    Chapter 542 Rapid Desensitization for Immediate Hypersensitivity to Galsulfase Therapy in Patients with MPS VI
Attention for Chapter 538: ECHS1 Deficiency as a Cause of Severe Neonatal Lactic Acidosis
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
ECHS1 Deficiency as a Cause of Severe Neonatal Lactic Acidosis
Chapter number 538
Book title
JIMD Reports, Volume 30
Published in
JIMD Reports, January 2016
DOI 10.1007/8904_2016_538
Pubmed ID
Book ISBNs
978-3-66-253680-3, 978-3-66-253681-0
Authors

Rebecca D. Ganetzky, Kaitlyn Bloom, Rebecca Ahrens-Nicklas, Andrew Edmondson, Matthew A. Deardorff, Michael J. Bennett, Can Ficicioglu, Ganetzky, Rebecca D., Bloom, Kaitlyn, Ahrens-Nicklas, Rebecca, Edmondson, Andrew, Deardorff, Matthew A., Bennett, Michael J., Ficicioglu, Can

Abstract

Mitochondrial short-chain enoyl-CoA hydratase deficiency (ECHS1D) is caused by mutations in ECHS1 (OMIM 602292) and is a recently identified inborn error of valine and fatty acid metabolism. This defect leads to secondary mitochondrial dysfunction. The majority of previously reported patients had the Leigh syndrome, with a median life expectancy of approximately 2 years. We report two siblings born 3 years apart with prenatal findings including facial dysmorphia, oligohydramnios, intrauterine growth restriction, and premature delivery. They had severe lactic acidosis with onset within the first hours of life, had congenital dilated cardiomyopathy, and died at 16 h of life and 2 days of life, respectively.Biochemical evaluation of these patients showed elevated butyryl-carnitine in the blood and elevated methylmalonyl/succinyl-CoA and decreased hydroxybutyryl-CoA in frozen liver of patient 2, confirming abnormal short-chain fatty acid metabolism. Elevated butyryl-carnitine has been reported only in a single previous case of ECHS1 deficiency, which also had neonatal onset. Pyruvate and lactate levels were both elevated with a normal pyruvate-lactate ratio. This supports the previous hypothesis that lactic acidosis in these patients results from secondary inhibition of the pyruvate dehydrogenase complex. The biomarker 2,3-dihydroxy-2-methylbutyric acid was detected in patient 2, but at lower levels than in previously reported cases.These cases extend our understanding of the severe end of the phenotypic spectrum of ECHS1 deficiency, clarify the range of biochemical abnormalities associated with this new disorder, and highlight the need to suspect this disease in patients presenting with comparable metabolic derangements and dysmorphic features.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 21%
Other 3 16%
Researcher 3 16%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Other 2 11%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 8 42%
Biochemistry, Genetics and Molecular Biology 3 16%
Agricultural and Biological Sciences 1 5%
Nursing and Health Professions 1 5%
Psychology 1 5%
Other 1 5%
Unknown 4 21%